Startup Origin Genomics is developing gene-editing technology to correct inherited diseases in human embryos, aiming to prove its safety for creating healthy babies despite legal and ethical concerns. #geneediting #News
Breaking: Engineered pancreatic islets survive long-term WITHOUT immunosuppression in first-in-human trial published in NEJM. A major breakthrough for… #Clinicaltrial #Diabetes #Geneediting #Immunology #Islettransplantation #Clinicaltrial #Diabetes #Geneediting #Immunology #Islettransplantation…
